Mechanism of the central hypotensive action of guanethidine.
D000818:Animals; D001921:Brain / Q000187:drug effects*; D002552:Cerebral Ventricles; D003042:Cocaine / Q000494:pharmacology; D004285:Dogs; D004983:Ethanolamines / Q000494:pharmacology; D006145:Guanethidine / Q000494:pharmacology*; D007267:Injections; D008750:Methyldopa / Q000494:pharmacology; D009638:Norepinephrine / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D012110:Reserpine / Q000494:pharmacology; D013747:Tetrabenazine / Q000494:pharmacology; D014191:Tranylcypromine / Q000494:pharmacology; D014666:Vasomotor System / Q000187:drug effects*
D004983:Ethanolamines; D010643:Phenoxybenzamine; D014191:Tranylcypromine; D008750:Methyldopa; D012110:Reserpine; D003042:Cocaine; D009638:Norepinephrine; D013747:Tetrabenazine; D006145:Guanethidine